glp-1 drug market size Antagonists Increase Plan Spend - What's Next GLP-1 Receptor Agonist Market Growth

: Wegovy an adjunct to diet and exercise to reduce body weight an maintain weight reduction to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established cardiovascular disease and either obesity or overweight

Nagata Y, Kanasaki A, Tamaru S, Tanaka K

Available from: Kosiborod MN, Bhatta M, Davies M, Deanfield JE, Garvey WT, Khalid U, Kushner R, Rubino DM, Zeuthen N, Verma S

Al-Aly says

[DOI] [PubMed] [Google Scholar] 118.Zinman B, Gerich J, Buse JB, Lewin A, Schwartz S, Raskin P, Hale PM, Zdravkovic M, Blonde L LEAD-4 Study Investigators

Braz Arch Endocrinol Metabol